// App-Quantinova.ai

2690 : VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study

Researchers

Presenter

  • Daria V Madeeva

Principal Investigators

  • Jana Christian

  • George Goshua

  • Hyung J. Chun

  • Alfred Ian Lee

  • Alexander B Pine

Medical Centers

  • Yale New Haven Hospital, New Haven, CT

  • Department of Medical Oncology, Yale University School of Medicine, New Haven, CT

  • Section of Endocrinology, Yale School of Medicine, New Haven, CT

  • Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT

  • Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT

  • Department of Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved